Your browser doesn't support javascript.
loading
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials.
Blumenfeld, Andrew M; Knievel, Kerry; Manack Adams, Aubrey; Severt, Lawrence; Butler, Matthew; Lai, Hongxin; Dodick, David W.
Affiliation
  • Blumenfeld AM; Headache Center of Southern California, 6010 Hidden Valley Rd #200, Carlsbad, CA, 92011, USA. Andrew.Blumenfeld@neurocenter.com.
  • Knievel K; Barrow Neurological Institute, Phoenix, AZ, USA.
  • Manack Adams A; AbbVie, Irvine, CA, USA.
  • Severt L; AbbVie, Madison, NJ, USA.
  • Butler M; AbbVie, Madison, NJ, USA.
  • Lai H; AbbVie, Madison, NJ, USA.
  • Dodick DW; Mayo Clinic, Phoenix, AZ, USA.
Adv Ther ; 39(1): 692-705, 2022 01.
Article in En | MEDLINE | ID: mdl-34874514
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Pyrroles / Calcitonin Gene-Related Peptide Receptor Antagonists / Migraine Disorders Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2022 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Pyrroles / Calcitonin Gene-Related Peptide Receptor Antagonists / Migraine Disorders Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2022 Type: Article Affiliation country: United States